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Abstract Researchers have begun to examine epigenetic
alterations in the placenta, making key advances in
understanding the epigenetic regulatory mechanisms of
the placenta that define underlying processes of human
development and disease. Examining changes in micro-
RNA (miRNA) expression associated with environmental
exposures and fetal growth is providing critical insights into
the biology of development, response to in utero exposure,
and future disease risk assessment. This review aims to
highlight previous studies describing changes in miRNA
expression in the human placenta associated with in utero
exposure and fetal growth and seeks to assess the future
directions in this exciting field of research.
Work in the developmental origins of health and disease has
shifted to investigating the molecular mechanisms of fetal
programming. Both in epidemiologic studies and model
systems, the focus is on one of the most important tissues
responsible for regulatingin utero development—the placenta.
The placenta can serve as a record of in utero exposure and
pathology (Maccani and Marsit 2009). A number of studies
have shown microRNA (miRNA) expressed in the human
placenta (Barad et al. 2004; Lim et al. 2005), generating
interest in further characterizing miRNA involvement in
placental function and in the development of miRNA
platforms with clinical utility as biomarkers of exposure or
disease (Mouillet et al. 2011; Maccani and Marsit 2009).
One common yet potentially hazardous environmental
exposure during pregnancy is cigarette smoke, and studies
have linked cigarette smoke exposure during pregnancy to
placental as well as fetal complications (Shiverick and
Salafia 1999; Argente et al. 2010). Maternal cigarette
smoking during pregnancy is associated with the down-
regulation of miR-16, miR-21, and miR-146a in term human
placental tissue, and two components of cigarette smoke,
nicotine and benzo(a)pyrene, result in the significant dose-
dependent downregulation of miR-146a in an in vitro
model (Maccani et al. 2010). Avissar-Whiting et al. showed
that miR-146a is particularly sensitive to dysregulation by
bisphenol A exposure in placental cell lines, further
suggesting that miR-146a may be especially sensitive to
modulation by exposure to these environmental toxicants
(Avissar-Whiting et al. 2010; Maccani et al. 2010). These
studies suggest that potentially hazardous environmental
toxicants may modulate miRNA expression in the placenta,
thereby underscoring the need for future work to better
understand the possible downstream effects of toxicant-
dysregulated miRNA expression in the placenta.
Future experiments aimed at further characterizing the
modulation of miRNA in the placenta by cigarette smoke and
other toxicants are needed. Experiments conducted using
cigarette smoke condensate, as reported by Crane-Godreau et
al. (2009), may prove especially useful in characterizing the
effects of complex mixtures of cigarette smoke components
on placental cells. Mouse models of chronic environmental
tobacco smoke exposure as described previously (Xiong et
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and examinations at multiple timepoints in pregnancy, could
elaborate on the normal and exposure-modulated roles of
miRNA in placenta function. Additionally, such findings
using an in vivo model system may provide key mechanistic
data that can further strengthen current epidemiologic
association studies.
Work to characterize associations of dysregulated
miRNA expression in the placenta with fetal growth is also
ongoing. Placental miRNA have been detected in maternal
plasma, and circulating miRNA and other circulating
nucleic acids have been detected in the maternal sera of
pregnant and non-pregnant women (Chim et al. 2008; Gilad
et al. 2008; Mouillet et al. 2010, 2011). Chim et al. (2008)
suggested that several placental miRNAs (miR-141, miR-
149, miR-299-5p,a n dmiR-135b) were highly expressed in
maternal plasma during pregnancy and noted that such
expression patterns may serve as clinical biomarkers for
pregnancy monitoring. Gilad et al. (2008) showed that sera
from pregnant women contained placental miRNA levels
higher than miRNA levels in sera from non-pregnant
women; additionally, they showed that miRNA levels in
the sera of pregnant women correlated with pregnancy
stage. Working with porcine placentas from day 30 and
day 90 of gestation, Su et al. (2010) showed differential
expression of miRNA associated with pregnancy stage.
A number of groups have also investigated associations
of miRNA expression specifically with fetal growth and
fetal growth restriction. Maccani et al. (2011) analyzed 107
human placenta samples for the expression of six candidate
miRNA previously shown to be expressed in the placenta
and suggested to regulate key cell and developmental
processes. They found that placental miR-16 and miR-21
expression was reduced in infants with the lowest birth-
weights and that low miR-16 expression in the placenta
predicted an increased odds for small for gestational age
(SGA) status using logistic regression models and control-
ling for other potential confounders (Maccani et al. 2011).
Moreover, low placental expression of both miR-16 and
miR-21 predicted a greater increased odds for SGA using
logistic regression models controlling for potential con-
founders than did only low miR-16 or low miR-21 alone
(Maccani et al. 2011). Mouillet et al. (2010) showed that
plasma levels of miRNA are regulated in pregnancy and
that fetal growth restriction may be associated with an
increase in circulating miRNA levels. Taken collectively,
these studies suggest that miRNA levels in the placenta as
well as placental miRNA detectable in maternal serum may
serve as important clinical biomarkers of pregnancy,
pregnancy stage, and other pregnancy-related outcomes
(Maccani and Marsit 2009; Prieto and Markert 2011).
Furthermore, work by Pineles et al. (2007) showed
differential expression of miRNA in placenta from patients
with preeclampsia, suggesting that differential placental
miRNA expression may have the clinical utility of being a
biomarker of preeclampsia. A further study by Patel et al.
(2011) demonstrated the modulation of specific miRNA
levels by placenta growth factor in endothelial cells, a result
which is quite interesting given the suggested role of
placenta growth factor in ensuring normal pregnancy
(Aubuchon et al. 2011). While many of these clinical
conditions of pregnancy can be measured by a suite of
current technologies, including ultrasound, miRNA bio-
markers of risk for a number of diseases of pregnancy, such
as preeclampsia, or even fetal risk for developing a
childhood disease may prove useful in giving clinicians
further tools to assess risk for disease in both pregnant
mother as well as fetus.
Future work further characterizing associations between
dysregulated miRNA expression in the placenta and assess-
ments offetal growth will be key in better understanding how
miRNA may be involved in regulating pathways of fetal
development and growth. A number of animal models have
been generated to further study low birthweight in a
controlled, experimental system (Desai et al. 2007; Tamashiro
and Moran 2010), and it will be important to consider the
role of miRNA in these animal models. Pernaute et al. (2011)
have made important steps in characterizing the roles of
miRNA in controlling cell cycle processes in the developing
mouse embryo as well as in extra-embryonic tissues. Several
studies have suggested that the insulin-like growth factor 2
(IGF-2) gene may be a major regulator of placental
development and function (Coan et al. 2008, 2010;
Constancia et al. 2002). As a result of this observation, it
may be of critical importance to identify miRNA that
reside within the IGF-2 gene, as well as miRNA that may
target the IGF-2 gene. Since IGF-2 signals through the Akt
and ERK pathways, alterations to either the expression of
miRNA or the potential targeting of IGF-2 by miRNA
may have major consequences both for the placenta and
for the developing fetus.
Future work may also include studying the effects of viral
or bacterial infections, such as sub-lethal doses of influenza A
(Mackenzieetal.1977) or LPS (Clark et al. 2004) at different
stages during pregnancy on placental miRNA expression in
model systems. One might hypothesize that miRNA partic-
ularly sensitive to infections and miRNA reported to be
involved in regulating inflammatory pathways, such as miR-
146a (Lu et al. 2010; Balasubramanyam et al. 2011;A r o n i c a
et al. 2010), might be especially sensitive to such infections.
Mice generated with placenta-specific knockdown of specific
miRNA using previously reported techniques for placental
gene manipulation (Georgiades et al. 2007) may also prove
essential in better characterizing the effect of dysregulated
miRNA expression on placental function and fetal growth
and development.
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Knowledge of the molecular mechanisms underlying
placental gene regulation may be enhanced by identifying
miRNA biomarkers for exposure, burden, or risk for
disease. Additionally, these aberrant patterns of miRNA
expression may identify previously unknown pathways
targeted for alteration, which can serve as targets for novel
drug treatment or prevention strategies, thereby bringing
miRNA diagnostics and therapeutics from benchtop to
bedside. Important advances in characterizing placental
miRNA expression associated with exposure and fetal
growth continue to elucidate a better understanding of the
epigenetic regulatory mechanisms of in the placenta. Future
work investigating the molecular mechanisms underlying
how cigarette smoke and other potentially hazardous in
utero exposures may alter the expression of placental
miRNA, as well as how such aberrant miRNA expression
patterns may lead to dysregulation of their target gene
protein levels, will be essential in further understanding the
effects of environmental exposures on placental function
and potentially downstream fetal programming.
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